卫光生物(002880.SZ)发布前三季度业绩，归母净利润1.58亿元，同比下降13.60%

Core Insights - The company reported a revenue of 791 million yuan for the first three quarters of 2025, representing a year-on-year decline of 7.40% [1] - The net profit attributable to shareholders of the listed company was 158 million yuan, down 13.60% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 155 million yuan, reflecting a year-on-year decrease of 12.67% [1]